• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用与e抗原血清阴性持续感染相关的序列替换前核心-核心启动子后,乙型肝炎病毒DNA的前核心转录减少,核心-前基因组转录增强。

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

作者信息

Moriyama K, Okamoto H, Tsuda F, Mayumi M

机构信息

Immunology Division, Jichi Medical School, Tochigi-Ken, Japan.

出版信息

Virology. 1996 Dec 15;226(2):269-80. doi: 10.1006/viro.1996.0655.

DOI:10.1006/viro.1996.0655
PMID:8955047
Abstract

Hepatitis B virus variants harboring nucleotide alterations in the preC-C promoter have been detected in fulminant hepatitis B as well as in HBeAg-seronegative persistent infection. However, it has not been demonstrated that variants with nucleotide alterations in the preC-C promoter cause various disease states. We replaced the preC-C promoter region of a wild-type genome with the most frequent naturally occurring mutated form and introduced it into HepG2 cells. The mutant with coexisting A1762T and G1764A substitutions produced less than one-fifth of the wild-type level of HBeAg. Conversely, the mutant generated 2.4 times more core particle antigen and showed a high-replicator phenotype. RNase protection and quantitative 5' RACE showed a 16- to 32-fold reduction of preC transcripts and a 4-fold induction of C transcripts of the mutant compared to wild-type. The preC transcript of the mutant had a more heterogeneous 5' end than that of the wildtype. However, the mutations did not alter the initiation sites of C transcription. When the promoter region was cloned into CAT plasmids, the mutations had dual effects on preC and C promoter activities, decreasing and increasing them, respectively. These results suggest that these mutations are responsible for the reduced HBeAg production as well as the enhanced replication and core production. Analysis of revertants with either single point mutation showed that T at 1762 is critical for the mutant phenotype.

摘要

在暴发性乙型肝炎以及HBeAg血清学阴性的持续性感染中,已检测到在前C-C启动子区域存在核苷酸改变的乙型肝炎病毒变异体。然而,尚未证实前C-C启动子区域存在核苷酸改变的变异体会导致各种疾病状态。我们用最常见的自然发生的突变形式替换了野生型基因组的前C-C启动子区域,并将其导入HepG2细胞。同时存在A1762T和G1764A替换的突变体产生的HBeAg水平不到野生型水平的五分之一。相反,该突变体产生的核心颗粒抗原多2.4倍,并表现出高复制子表型。核糖核酸酶保护和定量5' RACE显示,与野生型相比,突变体的前C转录本减少了16至32倍,C转录本增加了4倍。突变体的前C转录本5' 端比野生型更具异质性。然而,这些突变并未改变C转录的起始位点。当将启动子区域克隆到CAT质粒中时,这些突变对前C和C启动子活性具有双重影响,分别使其降低和增加。这些结果表明,这些突变是导致HBeAg产生减少以及复制和核心蛋白产生增强的原因。对单点突变回复体的分析表明,1762位的T对突变体表型至关重要。

相似文献

1
Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.用与e抗原血清阴性持续感染相关的序列替换前核心-核心启动子后,乙型肝炎病毒DNA的前核心转录减少,核心-前基因组转录增强。
Virology. 1996 Dec 15;226(2):269-80. doi: 10.1006/viro.1996.0655.
2
Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.e抗原阴性慢性乙型肝炎患者核心启动子/前核心区突变与病毒载量的相关性
J Viral Hepat. 2006 May;13(5):336-42. doi: 10.1111/j.1365-2893.2005.00688.x.
3
[The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].[韩国慢性乙型肝炎病毒感染患者前核心区和核心启动子突变的患病率及临床意义]
Taehan Kan Hakhoe Chi. 2002 Jun;8(2):149-56.
4
Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.血清学转换前存在乙肝病毒核心启动子突变可预测HBeAg消失后病毒持续复制。
J Clin Virol. 2007 Jul;39(3):199-204. doi: 10.1016/j.jcv.2007.04.008. Epub 2007 May 29.
5
Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.前核心启动子和前核心开放阅读框发生突变的乙型肝炎病毒基因组的生物学特性
Virology. 1997 Jul 7;233(2):374-81. doi: 10.1006/viro.1997.8594.
6
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.实体瘤患者接受细胞毒性化疗时的乙肝病毒再激活:前C区/核心区突变可能起重要作用。
J Med Virol. 2000 Mar;60(3):249-55.
7
Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.慢性乙型肝炎病毒感染患者中乙型肝炎病毒增强子2/核心启动子区域突变的检测:与前核心和核心区域突变在临床状况方面的比较
J Med Virol. 1999 Apr;57(4):337-44.
8
Mutations in the transcriptional regulatory region of the precore and core/pregenome of a hepatitis B virus with defective HBeAg production.乙型肝炎病毒前核心区及核心/前基因组转录调控区的突变与HBeAg产生缺陷有关。
Fukuoka Igaku Zasshi. 1994 Nov;85(11):314-22.
9
Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion.在乙肝e抗原血清学转换过程中,不同的乙肝病毒基因型与核心启动子及前核心区的不同突变相关。
Hepatology. 1999 Mar;29(3):976-84. doi: 10.1002/hep.510290352.
10
Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis.从越南暴发性肝炎患者中分离出的乙型肝炎病毒基因组特性与急性肝炎患者的比较。
J Med Virol. 2000 May;61(1):23-8.

引用本文的文献

1
Identification of low-molecular compounds that inhibit envelope formation of hepatitis B virus.鉴定抑制乙型肝炎病毒包膜形成的低分子化合物。
Sci Rep. 2025 Jul 8;15(1):24344. doi: 10.1038/s41598-025-10473-5.
2
Clinical isolates of hepatitis B virus genotype C have higher in vitro transmission efficiency than genotype B isolates.乙型肝炎病毒 C 基因型的临床分离株比 B 基因型的分离株具有更高的体外传播效率。
J Med Virol. 2023 Jun;95(6):e28879. doi: 10.1002/jmv.28879.
3
Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B.
在初发乙型肝炎 e 抗原阴性慢性乙型肝炎患者中,血清乙型肝炎病毒 RNA 可检测性、组成及临床意义。
Virol J. 2022 Jan 29;19(1):22. doi: 10.1186/s12985-022-01749-7.
4
Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins.乙型肝炎病毒相关性肝细胞癌的血液生物标志物,包括病毒基因组和糖基化蛋白。
Int J Mol Sci. 2021 Oct 13;22(20):11051. doi: 10.3390/ijms222011051.
5
Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication.自然发生的 PreS1 缺失突变乙型肝炎病毒的丢失小信封蛋白表达通常伴随着 HBx 和核心蛋白表达以及基因组复制的增加。
J Virol. 2021 Jun 24;95(14):e0066021. doi: 10.1128/JVI.00660-21.
6
Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection.通过针对前核心独特表位的抗体特异性检测乙型肝炎 e 抗原,有助于临床诊断和评估乙型肝炎病毒感染的药物治疗。
Emerg Microbes Infect. 2021 Dec;10(1):37-50. doi: 10.1080/22221751.2020.1862631.
7
Quadruple mutation GCAC1809-1812TTCT acts as a biomarker in healthy European HBV carriers.四重突变 GCAC1809-1812TTCT 可作为健康欧洲 HBV 携带者的生物标志物。
JCI Insight. 2020 Nov 19;5(22):135833. doi: 10.1172/jci.insight.135833.
8
An antiviral drug-resistant mutant of hepatitis B virus with high replication capacity in association with a large in-frame deletion in the preS1 region of viral surface gene.乙型肝炎病毒抗病毒药物耐药突变株,其前 S1 区病毒表面基因发生大片段框内缺失,复制能力增强。
Virus Genes. 2020 Dec;56(6):677-686. doi: 10.1007/s11262-020-01787-9. Epub 2020 Aug 25.
9
Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants.野生型乙肝病毒与前核心区(G1896A)或核心启动子区(A1762T/G1764A)突变体之间乙肝病毒复制、载脂蛋白B mRNA编辑酶催化多肽样3(APOBEC3)家族表达及炎性细胞因子水平的差异
Front Microbiol. 2020 Jul 14;11:1653. doi: 10.3389/fmicb.2020.01653. eCollection 2020.
10
High Frequency of Either Altered Pre-Core StartCodon or Weakened Kozak Sequence in the CorePromoter Region in Hepatitis B Virus A1 Strainsfrom Rwanda.卢旺达乙型肝炎病毒 A1 株中核心启动子区前核心起始密码子改变或 Kozak 序列减弱的高频发生。
Genes (Basel). 2019 Feb 26;10(3):182. doi: 10.3390/genes10030182.